Interestingly, circulating SELENOP is studied as a potential mediator of metabolic disorder and, although mechanisms involving the pancreas and BAT were reported, the physiological effects of SELENOP in the hypothalamus were not reported on [163,164,165]. Here, SELENOP is linked to metabolic disease.